File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1086/313809
- Scopus: eid_2-s2.0-0034463167
- PMID: 10880300
- WOS: WOS:000088525400009
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Immunorestitution disease involving the innate and adaptive response
Title | Immunorestitution disease involving the innate and adaptive response |
---|---|
Authors | |
Issue Date | 2000 |
Publisher | Oxford University Press. The Journal's web site is located at http://www.oxfordjournals.org/our_journals/cid/ |
Citation | Clinical Infectious Diseases, 2000, v. 30 n. 6, p. 882-892 How to Cite? |
Abstract | Immunorestitution disease (IRD) is defined as an acute symptomatic or paradoxical deterioration of a (presumably) preexisting infection that is temporally related to the recovery of the immune system. We report the temporal sequence of events that led to IRD caused by Pneumocystis carinii and Aspergillus terreus in 2 human immunodeficiency virus (HIV)-negative patients soon after the recovery of adaptive and innate immunity, respectively, and we review episodes noted in the English-language literature that fit the definition of IRD (109 episodes in 107 patients). The median time from the recovery of neutrophil counts or termination of steroid therapy to the development of IRD was 8 days in cases of pulmonary aspergillosis (23 episodes) and hepatosplenic candidiasis (8) and 21 days for viral diseases such as hepatitis B (24) and viral pneumonitis (6). For IRD due to mycobacteriosis (27 episodes) and cryptococcosis (4) in HIV-positive patients, the median interval between the initiation of highly active antiretroviral therapy (HAART) and the onset of IRD was 11 days; for viral infections, including those due to cytomegalovirus (14), hepatitis B virus (1), and hepatitis C virus (2), the median interval was 42 days. As an emerging clinical entity, IRD merits further study to optimize treatment of immunosuppressed patients. |
Persistent Identifier | http://hdl.handle.net/10722/43094 |
ISSN | 2023 Impact Factor: 8.2 2023 SCImago Journal Rankings: 3.308 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheng, VCC | en_HK |
dc.contributor.author | Yuen, KY | en_HK |
dc.contributor.author | Chan, WM | en_HK |
dc.contributor.author | Wong, SSY | en_HK |
dc.contributor.author | Ma, ESK | en_HK |
dc.contributor.author | Chan, RMT | en_HK |
dc.date.accessioned | 2007-03-23T04:38:43Z | - |
dc.date.available | 2007-03-23T04:38:43Z | - |
dc.date.issued | 2000 | en_HK |
dc.identifier.citation | Clinical Infectious Diseases, 2000, v. 30 n. 6, p. 882-892 | en_HK |
dc.identifier.issn | 1058-4838 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/43094 | - |
dc.description.abstract | Immunorestitution disease (IRD) is defined as an acute symptomatic or paradoxical deterioration of a (presumably) preexisting infection that is temporally related to the recovery of the immune system. We report the temporal sequence of events that led to IRD caused by Pneumocystis carinii and Aspergillus terreus in 2 human immunodeficiency virus (HIV)-negative patients soon after the recovery of adaptive and innate immunity, respectively, and we review episodes noted in the English-language literature that fit the definition of IRD (109 episodes in 107 patients). The median time from the recovery of neutrophil counts or termination of steroid therapy to the development of IRD was 8 days in cases of pulmonary aspergillosis (23 episodes) and hepatosplenic candidiasis (8) and 21 days for viral diseases such as hepatitis B (24) and viral pneumonitis (6). For IRD due to mycobacteriosis (27 episodes) and cryptococcosis (4) in HIV-positive patients, the median interval between the initiation of highly active antiretroviral therapy (HAART) and the onset of IRD was 11 days; for viral infections, including those due to cytomegalovirus (14), hepatitis B virus (1), and hepatitis C virus (2), the median interval was 42 days. As an emerging clinical entity, IRD merits further study to optimize treatment of immunosuppressed patients. | en_HK |
dc.format.extent | 125710 bytes | - |
dc.format.extent | 30720 bytes | - |
dc.format.mimetype | application/pdf | - |
dc.format.mimetype | application/msword | - |
dc.language | eng | en_HK |
dc.publisher | Oxford University Press. The Journal's web site is located at http://www.oxfordjournals.org/our_journals/cid/ | en_HK |
dc.relation.ispartof | Clinical Infectious Diseases | en_HK |
dc.rights | Clinical Infectious Diseases. Copyright © University of Chicago Press. | en_HK |
dc.subject.mesh | Aspergillosis - immunology - microbiology | en_HK |
dc.subject.mesh | Immunity, active | en_HK |
dc.subject.mesh | Immunity, natural | en_HK |
dc.subject.mesh | Lung diseases, fungal - immunology - microbiology | en_HK |
dc.subject.mesh | Pneumocystis - immunology | en_HK |
dc.title | Immunorestitution disease involving the innate and adaptive response | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1058-4838&volume=30&issue=6&spage=882&epage=892&date=2000&atitle=Immunorestitution+Disease+Involving+the+Innate+and+Adaptive+Response | en_HK |
dc.identifier.email | Yuen, KY:kyyuen@hkucc.hku.hk | en_HK |
dc.identifier.email | Wong, SSY:samsonsy@hkucc.hku.hk | en_HK |
dc.identifier.authority | Yuen, KY=rp00366 | en_HK |
dc.identifier.authority | Wong, SSY=rp00395 | en_HK |
dc.description.nature | published_or_final_version | en_HK |
dc.identifier.doi | 10.1086/313809 | en_HK |
dc.identifier.pmid | 10880300 | - |
dc.identifier.scopus | eid_2-s2.0-0034463167 | en_HK |
dc.identifier.hkuros | 54349 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0034463167&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 30 | en_HK |
dc.identifier.issue | 6 | en_HK |
dc.identifier.spage | 882 | en_HK |
dc.identifier.epage | 892 | en_HK |
dc.identifier.isi | WOS:000088525400009 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Cheng, VCC=23670479400 | en_HK |
dc.identifier.scopusauthorid | Yuen, KY=36078079100 | en_HK |
dc.identifier.scopusauthorid | Chan, WM=36338834700 | en_HK |
dc.identifier.scopusauthorid | Wong, SSY=13310021400 | en_HK |
dc.identifier.scopusauthorid | Ma, ESK=24725277400 | en_HK |
dc.identifier.scopusauthorid | Chan, RMT=7403110774 | en_HK |
dc.identifier.issnl | 1058-4838 | - |